Navigation Links
Stop Ripping Me Off! Is the Title of a New Consumer Protection Book Being Released Today
Date:3/16/2010

A new book outlining a “game changing” way to fix, remodel or build a home will be released today. This new concept protects consumers by enabling them to pay less, get more, and to have real protection from contractor fraud, poor home construction, poor health from a sick home, and legal problems relating to the construction.

(PRWEB) March 16, 2010 -- Stop Ripping Me Off! is the title of a new book written by Karl Auleciems of West Lakeland Minnesota outlining a new and revolutionary way to fix, remodel or build a home. The process results in paying less, getting more home for the money, increased quality, and real protection from contractor fraud. This book and process is a “game changer” for the residential construction market and will effect large building corporations like Pulte Homes and Toll Brothers, Inc.

Karl Auleciems is an entrepreneur who started building homes as a hobby and gradually moved to building multi-mullion dollar homes for far less than what other contractors could build them for and selling them for large non-speculative gains.

Karl Auleciems writes in his book that the current home remodeling/building market is broken. Homeowners are overpaying for the remodel or build, receiving poor quality, and being put at risk for legal, financial, and health problems and don’t even know it. “We have financial advisors, legal advisors (lawyers), medical advisors (doctors), and no construction advisors, yet we spend more on our homes than all other advisor categories combined,” said Karl Auleciems.

“The secret to paying less, getting more for your money, and
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Stripping leukemia-initiating cells of their invisibility cloak
2. Medical Malpractice Survivors Decry Possible Stripping of Rights in Presidents Health Care Plan
3. Public Health Reports Will Host A Meet the Author! Webcast Entitled How Healthy Could a State Be
4. Health Connect Partners Welcomes Cardinal Health as Three-Year Title Sponsor
5. Trek Bicycle Announces Title Sponsorship of 2010 Dirt Series
6. Duke Medicine Becomes Tobacco Road Marathon Title Sponsor
7. Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset
8. Celebrities Vie For Who Wears Purple Best? Title to Raise Awareness of New Global Prevalence On World Alzheimers Day
9. UFC Title Fight Has Stacked Advantage
10. Irish Joe McCreedy Defends Title, Fights for New One With Superhydration From AquaHydrate, First High Performance Sports Water
11. Hitachi Medical Systems and Monarch Medical Announced as Co- Title Sponsors of the Health Connect Partners 2009 Fall Radiology and Imaging Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... of Medicine researchers have been awarded two-year grants for ... announced this month. Of the 110 initial submissions to ... Forum Program, only four projects were funded, three of ... Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; and ... professor of oncology, will use his $500,000 proof of ...
(Date:4/18/2014)... in French . ... and regenerative medicine. A team led by Ludwik Leibler ... Tech) and Didier Letourneur from the Laboratoire Recherche Vasculaire ... demonstrated that the principle of adhesion by aqueous solutions ... soft-tissue organs and tissues. This easy-to-use gluing method has ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... 21 BET News correspondent, Andre Showell will lead the discussion during ... Wednesday, July 22 ( ) at 8 ... broadcast of the entire news conference along with pre and post analysis ... The President is expected to discuss health care legislation and ...
... LOUIS, July 21 Young Innovations, Inc. (Nasdaq: YDNT ) ... $0.04 per share, payable September 15, 2009 to all shareholders of record ... of up to 500,000 shares of the Company,s stock. This authorization, which ... scheduled to expire on July 31, 2009. , , ...
... , , FRANKLIN, Tenn., July 21 ... documentation technology and services, today announced details for the release of its ... , Spheris plans to issue its earnings ... trading on Thursday, August 6, 2009, and will host a conference call ...
... , , HOUSTON, July 21 ... of fiscal 2009 on Thursday, August 6, 2009. , , ... at 11 a.m. ET following distribution of the earnings release. Additional information will ... the News Room on the day of the earnings announcement. , ...
... Ill., July 21 Since 2003, the University HealthSystem Consortium (UHC) has ... the sixth consecutive year. The Honor Roll publicly recognizes and celebrates all ... , All Honor Roll recipients must exhibit 10 ... a work environment founded on dignity and respect for all employees , ...
... MEQUON, Wis., July 21 Wonderbox Technologies has ... to benefit from continued advances in technology and software features. ... designed for managed care benefit administration and case management. The ... scheduling, managing, and monitoring day-to-day care tasks and case assignments. ...
Cached Medicine News:Health News:BET Networks Airs Special Coverage of President Obama's News Conference on Health Care 2Health News:Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 2Health News:Spheris Sets Second Quarter 2009 Earnings Release and Conference Call Dates 2Health News:US Oncology to Report 2009 Second Quarter Operating Results 2Health News:University HealthSystem Consortium Recognized as a Company That Cares for Sixth Year in a Row 2Health News:Wonderbox Technologies(R) Releases Version 4.5 of the Enterprise System 2
(Date:1/15/2014)... BOSTON , Jan. 15, 2014 Tegra Medical is ... Mark King as its new Chief Executive Officer.  Mark ... in which he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in 2012 ...
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... Bermuda, Dec. 16 Celtic Pharmaceutical Holdings L.P. ("Celtic ... preliminary analyses completed on the two double-blinded studies of XERECEPT ... edema, as well as an initial database lock on the ... , The results of these studies ...
... Live Broadcast on December 18, 2008 at 9 a.m. Eastern Time ... MannKind Corporation (Nasdaq: MNKD ) will host ... 3 studies of AFRESA(TM), the company,s ultra rapid acting, inhaled insulin product, ... , , To participate in the live ...
Cached Medicine Technology:Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009 2MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: